Literature DB >> 20487120

Autonomic dysfunction and new-onset atrial fibrillation in patients with left ventricular systolic dysfunction after acute myocardial infarction: a CARISMA substudy.

Christian Jons1, Pekka Raatikainen, Uffe J Gang, Heikki V Huikuri, Rikke Moerch Joergensen, Arne Johannesen, Ulrik Dixen, Marc Messier, Scott McNitt, Poul Erik Bloch Thomsen.   

Abstract

BACKGROUND: Atrial fibrillation (AF) increases morbidity and mortality in patients with previous myocardial infarction and left ventricular systolic dysfunction. The purpose of this study was to identify patients with a high risk for new-onset AF in this population using invasive and noninvasive electrophysiological tests.
METHODS: The study included 271 patients from the Cardiac Arrhythmias and RIsk Stratification after Myocardial InfArction (CARISMA) study with an acute myocardial infarction (AMI) and left ventricular ejection fraction ≤40% without previous AF at enrollment. Within 21 days after the AMI, an implantable loop recorder was inserted and used to diagnose AF over the 2-year study duration. The following tests were performed: heart rate variability (HRV) and turbulence (HRT) analyses from repeated 24-hour Holter recordings, 2-dimensional (2D)-echocardiograms, exercise test, and programmed electrophysiologic stimulation.
RESULTS: A total of 101 patients (37%) developed AF during the study. Predictive measures included several indexes of HRV including reduced low-frequency (LF) power from spectral HRV analysis (adjusted HR = 1.6, P = 0.034), HRT slope ≤2.5 (HR = 1.6, P = 0.032) and Detrended Fluctuation Analysis (DFA1) from HRV analysis (HR = 1.8, P = 0.011); all are measures of cardiac autonomic nervous system dysfunction. Combined with age >60 years, low values for LF, HRT slope, and DFA1 provided a powerful risk score for prediction of new-onset AF (1-2 points: HR = 4.3, P = 0.001, 3-4 points: HR = 7.0, P < 0.001).
CONCLUSION: Abnormal HRV and HRT parameters, which are associated with disturbances in the cardiac autonomic regulation, are associated with increased risk of new-onset AF independently of conventional clinical risk variables.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20487120     DOI: 10.1111/j.1540-8167.2010.01795.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  18 in total

Review 1.  Dysfunction of the autonomic nervous system in atrial fibrillation.

Authors:  Yutao Xi; Jie Cheng
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

2.  Holter monitoring to detect silent atrial fibrillation in high-risk subjects: the Perugia General Practitioner Study.

Authors:  Valentina Salvatori; Cecilia Becattini; Stefano Laureti; Gregorio Baglioni; Fabrizio Germini; Piero Grilli; Francesco Guercini; Esmeralda Filippucci; Giancarlo Agnelli
Journal:  Intern Emerg Med       Date:  2015-05-06       Impact factor: 3.397

Review 3.  Mortality Risk Associated with AF in Myocardial Infarction Patients.

Authors:  Rajiv Sankaranarayanan
Journal:  J Atr Fibrillation       Date:  2012-10-06

4.  Postural changes in blood pressure and incidence of ischemic stroke subtypes: the ARIC study.

Authors:  Hiroshi Yatsuya; Aaron R Folsom; Alvaro Alonso; Rebecca F Gottesman; Kathryn M Rose
Journal:  Hypertension       Date:  2011-01-03       Impact factor: 10.190

Review 5.  Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.

Authors:  Paulus Kirchhof; Gregory Y H Lip; Isabelle C Van Gelder; Jeroen Bax; Elaine Hylek; Stefan Kaab; Ulrich Schotten; Karl Wegscheider; Giuseppe Boriani; Axel Brandes; Michael Ezekowitz; Hans Diener; Laurent Haegeli; Hein Heidbuchel; Deirdre Lane; Luis Mont; Stephan Willems; Paul Dorian; Maria Aunes-Jansson; Carina Blomstrom-Lundqvist; Maria Borentain; Stefanie Breitenstein; Martina Brueckmann; Nilo Cater; Andreas Clemens; Dobromir Dobrev; Sergio Dubner; Nils G Edvardsson; Leif Friberg; Andreas Goette; Michele Gulizia; Robert Hatala; Jenny Horwood; Lukas Szumowski; Lukas Kappenberger; Josef Kautzner; Angelika Leute; Trudie Lobban; Ralf Meyer; Jay Millerhagen; John Morgan; Felix Muenzel; Michael Nabauer; Christoph Baertels; Michael Oeff; Dieter Paar; Juergen Polifka; Ursula Ravens; Ludger Rosin; W Stegink; Gerhard Steinbeck; Panos Vardas; Alphons Vincent; Maureen Walter; Günter Breithardt; A John Camm
Journal:  Europace       Date:  2011-07-26       Impact factor: 5.214

Review 6.  Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome.

Authors:  J Wang; Y-M Yang; J Zhu
Journal:  Herz       Date:  2014-10-30       Impact factor: 1.443

7.  New-onset atrial fibrillation after acute coronary syndrome: prevalence and predictive factors.

Authors:  Manel Ben Halima; Wael Yaakoubi; Selim Boudiche; Bassem Rekik; Fathia Zghal Mghaieth; Sana Ouali; Mohamed Sami Mourali
Journal:  Tunis Med       Date:  2022 fevrier

Review 8.  Neuroscientific therapies for atrial fibrillation.

Authors:  Peter Hanna; Eric Buch; Stavros Stavrakis; Christian Meyer; John D Tompkins; Jeffrey L Ardell; Kalyanam Shivkumar
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

Review 9.  The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation.

Authors:  Constanze Schmidt; Jana Kisselbach; Patrick A Schweizer; Hugo A Katus; Dierk Thomas
Journal:  Vasc Health Risk Manag       Date:  2011-03-31

Review 10.  Atrial fibrillation in acute ST-elevation myocardial infarction: clinical and prognostic features.

Authors:  Bulent Gorenek; Gulmira Kudaiberdieva
Journal:  Curr Cardiol Rev       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.